TABLE 1.
Baseline characteristics.
| Characteristics | (N, %) |
| Total number of patients | 75 |
| Age median (%95 CI) | 64.0 (61.0–65.0) |
| Male/Female | 32 (42.7%)/43 (57.3%) |
| Current smokers/Ex-smokers/Never smokers | 7 (9.3%)/38 (50.7%)/11 (40.0%) |
| FVC% predicted ± SD | 76.5 ± 22.3 |
| DLCO% predicted ± SD | 59.1 ± 27.7 |
| BAL Macrophages% median (%95 CI) | 64.0 (59.7–75.7) |
| BAL Lymphocytes% predicted median (%95 CI) | 15.5 (6.0–22.7) |
| BAL Neutrophils% predicted median (%95 CI) | 8.0 (3.0–11.0) |
| BAL Eosinophils% predicted median (%95 CI) | 1.0 (0.0–3.0) |
| ILD onset first | 29 (38.7%) |
| Concomitant diagnosis of ILD/myopathy | 16 (21.3%) |
| Myopathy onset first | 30 (40.0%) |
| Arterial hypertension | 28 (37.3%) |
| Gastroesophageal reflux disease | 14 (18.7%) |
| Hypothyroidism | 11 (14.7%) |
| Diabetes mellitus | 9 (12.0%) |
| Chronic heart disease | 9 (12.0%) |
| Cancer | 8 (10.7%) |
BAL, bronchoalveolar lavage; CI, confidence interval; DLCO, diffusing capacity of lung for carbon monoxide; FVC, forced vital capacity; ILD, interstitial lung disease; SD, standard deviation.